Effect of Biliary Drainage on the Prognosis of Patients with Hepatocellular Carcinoma and Bile Duct Invasion
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Bile duct invasion (BDI) is rarely observed in patients with advanced hepatocellular carcinoma (HCC), leading to hyperbilirubinemia. However, the efficacy of pretreatment biliary drainage for HCC patients with BDI and obstructive jaundice is currently unclear. Thus, the aim of this study was to assess the effect of biliary drainage on the prognosis of these patients. Methods: We retrospectively enrolled a total of 200 HCC patients with BDI from multicenter cohorts. Patients without obstructive jaundice (n=99) and those who did not undergo HCC treatment (n=37) were excluded from further analysis. Finally, 64 patients with obstructive jaundice (43 subjected to drainage and 21 not subjected to drainage) were included. Propensity score matching was then conducted. Results: The biliary drainage group showed longer overall survival (median 10.13 months vs 4.43 months, p=0.004) and progression-free survival durations (median 7.00 months vs 1.97 months, p<0.001) than the non-drainage group. Multivariate analysis showed that biliary drainage was a significantly favorable prognostic factor for overall survival (hazard ratio, 0.42; p=0.006) and progression-free survival (hazard ratio, 0.30; p<0.001). Furthermore, in the evaluation of first response after HCC treatment, biliary drainage was beneficial (p=0.005). Remarkably, the durations of overall survival (p=0.032) and progression-free survival (p=0.004) were similar after propensity score matching. Conclusions: Biliary drainage is an independent favorable prognostic factor for HCC patients with BDI and obstructive jaundice. Therefore, biliary drainage should be contemplated in the treatment of advanced HCC with BDI to improve survival outcomes.
Abstract
Background/Aims: Bile duct invasion (BDI) is rarely observed in patients with advanced hepatocellular carcinoma (HCC), leading to hyperbilirubinemia. However, the efficacy of pretreatment biliary drainage for HCC patients with BDI and obstructive jaundice is currently unclear. Thus, the aim of this study was to assess the effect of biliary drainage on the prognosis of these patients. Methods: We retrospectively enrolled a total of 200 HCC patients with BDI from multicenter cohorts. Patients without obstructive jaundice (n=99) and those who did not undergo HCC treatment (n=37) were excluded from further analysis. Finally, 64 patients with obstructive jaundice (43 subjected to drainage and 21 not subjected to drainage) were included. Propensity score matching was then conducted. Results: The biliary drainage group showed longer overall survival (median 10.13 months vs 4.43 months, p=0.004) and progression-free survival durations (median 7.00 months vs 1.97 months, p<0.001) than the non-drainage group. Multivariate analysis showed that biliary drainage was a significantly favorable prognostic factor for overall survival (hazard ratio, 0.42; p=0.006) and progression-free survival (hazard ratio, 0.30; p<0.001). Furthermore, in the evaluation of first response after HCC treatment, biliary drainage was beneficial (p=0.005). Remarkably, the durations of overall survival (p=0.032) and progression-free survival (p=0.004) were similar after propensity score matching. Conclusions: Biliary drainage is an independent favorable prognostic factor for HCC patients with BDI and obstructive jaundice. Therefore, biliary drainage should be contemplated in the treatment of advanced HCC with BDI to improve survival outcomes.
참고문헌 (31)
- Yang JD, "A global view of hepatocellular carcinoma : trends, risk, prevention and management", Nat Rev Gastroenterol Hepatol, 16, pp.589~604 (2019)
- Sung H, "Global cancer statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 71, pp.209~249 (2021)
- Balogh J, "Hepatocellular carcinoma : a review", J Hepatocell Carcinoma, 3, pp.41~53 (2016)
- Ikenaga N, "Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion", J Gastrointest Surg, 13, pp.492~497 (2009)
- Huang JF, "Incidence and clinical outcome of icteric type hepatocellular carcinoma", J Gastroenterol Hepatol, 17, pp.190~195 (2002)
- Qin LX, "Hepatocellular carcinoma with obstructive jaundice : diagnosis, treatment and prognosis", World J Gastroenterol, 9, pp.385~391 (2003)
- Meng KW, "Clinical characteristics and surgical prognosis of hepatocellular carcinoma with bile duct invasion", Gastroenterol Res Pract, 2014, pp.604971~ (2014)
- Jang YR, "Bile duct invasion can be an independent prognostic factor in early stage hepatocellular carcinoma", Korean J Hepatobiliary Pancreat Surg, 19, pp.167~172 (2015)
- An J, "Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion", Clin Mol Hepatol, 23, pp.160~169 (2017)
- Huang Q, "Redefining hepatocellular carcinoma staging systems based on the bile duct invasion status : a multicenter study", Front Oncol, 11, pp.673285~ (2021)
- Yang X, "Prognostic importance of bile duct invasion in surgical resection with curative intent for hepatocellular carcinoma using PSM analysis", Oncol Lett, 16, pp.3593~3602 (2018)
- Huang Q, "Prognosis value of microscopicbile duct invasion in hepatocellular carcinoma : a multicenter study", Cancer Med, 12, pp.20821~20829 (2023)
- Jiang W, "Effect of biliary tract invasion with obstructive jaundice on the prognosis of patients with unresectable hepatocellular carcinoma", Acad Radiol, 30, pp.483~491 (2023)
- Heimbach JK, "AASLD guidelines for the treatment of hepatocellular carcinoma", Hepatology, 67, pp.358~380 (2018)
- European Association for the Study of the Liver, "EASL clinical practice guidelines : management of hepatocellular carcinoma", J Hepatol, 69, pp.182~236 (2018)
- Reig M, "BCLC strategy for prognosis prediction and treatment recommendation : the 2022update", J Hepatol, 76, pp.681~693 (2022)
- Omata M, "Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma : a 2017 update", Hepatol Int, 11, pp.317~370 (2017)
- Zhou J, "Guidelines for the diagnosis and treatment of hepatocellular carcinoma(2019 edition)", Liver Cancer, 9, pp.682~720 (2020)
- Matsueda K, "Effectiveness of endoscopic biliary drainage for unresectable hepatocellular carcinoma associated with obstructive jaundice", J Gastroenterol, 36, pp.173~180 (2001)
- Hong HP, "Percutaneous metallic stents in patients with obstructive jaundice due to hepatocellular carcinoma", J Vasc Interv Radiol, 19, pp.748~754 (2008)
- Cho HC, "Are endoscopic or percutaneous biliary drainage effective for obstructive jaundice caused by hepatocellular carcinoma?", Eur J Gastroenterol Hepatol, 23, pp.224~231 (2011)
- Suh YG, "Effective biliary drainage and proper treatment improve outcomes of hepatocellular carcinoma with obstructive jaundice", Gut Liver, 8, pp.526~535 (2014)
- Sugiyama G, "Evaluation of endoscopic biliary stenting for obstructive jaundice caused by hepatocellular carcinoma", World J Gastroenterol, 20, pp.6968~6973 (2014)
- Woo HY, "Role of endoscopic biliary drainage in advanced hepatocellular carcinoma with jaundice", PLoS One, 12, pp.e0187469~ (2017)
- Matsumi A, "Effectiveness, safety, and factors associated with the clinical success of endoscopic biliary drainage for patients with hepatocellular carcinoma : a retrospective multicenter study", BMC Gastroenterol, 21, pp.28~ (2021)
- Park J, "Chemoembolisation for hepatocellular carcinoma with bile duct invasion : is preprocedural biliary drainage mandatory?", Eur Radiol, 28, pp.1540~1550 (2018)
- Lau W, "A logical approach to hepatocellular carcinoma presenting with jaundice", Ann Surg, 225, pp.281~285 (1997)
- Hiraoka A, "Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584Japanese patients with hepatocellular carcinoma", J Gastroenterol Hepatol, 31, pp.1031~1036 (2016)
- Wang YY, "Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma", Br J Surg, 103, pp.725~734 (2016)
- Tangkijvanich P, "Clinical characteristics and prognosis of hepatocellular carcinoma : analysis based on serum alpha-fetoprotein levels", J Clin Gastroenterol, 31, pp.302~308 (2000)
- Galle PR, "Biology and significance of alpha-fetoprotein in hepatocellular carcinoma", Liver Int, 39, pp.2214~2229 (2019)